- Home
- POAI vs CNSP Comparison
POAI vs CNSP Comparison
Compare POAI & CNSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- POAI
- CNSP
- Stock Information
- Founded
- POAI 2002
- CNSP 2017
- Country
- POAI United States
- CNSP United States
- Employees
- POAI N/A
- CNSP N/A
- Industry
- POAI Industrial Specialties
- CNSP Biotechnology: Pharmaceutical Preparations
- Sector
- POAI Health Care
- CNSP Health Care
- Exchange
- POAI Nasdaq
- CNSP Nasdaq
- Market Cap
- POAI 4.9M
- CNSP 5.4M
- IPO Year
- POAI N/A
- CNSP 2019
- Fundamental
- Price
- POAI $0.71
- CNSP $0.11
- Analyst Decision
- POAI Hold
- CNSP Strong Buy
- Analyst Count
- POAI 1
- CNSP 1
- Target Price
- POAI N/A
- CNSP $0.50
- AVG Volume (30 Days)
- POAI 98.3K
- CNSP 6.2M
- Earning Date
- POAI 11-12-2024
- CNSP 11-15-2024
- Dividend Yield
- POAI N/A
- CNSP N/A
- EPS Growth
- POAI N/A
- CNSP N/A
- EPS
- POAI N/A
- CNSP N/A
- Revenue
- POAI $1,484,223.00
- CNSP N/A
- Revenue This Year
- POAI N/A
- CNSP N/A
- Revenue Next Year
- POAI $569.48
- CNSP N/A
- P/E Ratio
- POAI N/A
- CNSP N/A
- Revenue Growth
- POAI N/A
- CNSP N/A
- 52 Week Low
- POAI $0.55
- CNSP $0.10
- 52 Week High
- POAI $3.76
- CNSP $71.00
- Technical
- Relative Strength Index (RSI)
- POAI 47.04
- CNSP 49.04
- Support Level
- POAI $0.69
- CNSP $0.10
- Resistance Level
- POAI $0.80
- CNSP $0.12
- Average True Range (ATR)
- POAI 0.06
- CNSP 0.01
- MACD
- POAI -0.01
- CNSP 0.00
- Stochastic Oscillator
- POAI 25.93
- CNSP 56.90
About POAI Predictive Oncology Inc.
Predictive Oncology Inc functions in the healthcare domain. The firm's reportable segments are Pittsburgh segment that provides services which include the application of AI using its proprietary biobank of 150,000+ tumor samples. It also creates proprietary 3D culture models used in drug development; Birmingham segment that provides contract services and research focused on solubility improvements, stability studies, and protein production; and Eagan segment that produces the FDA-cleared STREAMWAY System and associated products for automated medical fluid waste management and patient-to-drain medical fluid disposal. It derives maximum revenue from Eagan Segment.
About CNSP CNS Pharmaceuticals Inc.
CNS Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the development of anticancer drug candidates for the treatment of primary and metastatic brain and central nervous system tumors. It is involved in the development of Berubicin, which is a therapy for the treatment of glioblastoma. Glioblastomas are tumors that arise from astrocytes, which are star-shaped cells that make up the supportive tissue of the brain.